Abstract
Single-domain antibodies, or VHH, represent an attractive molecular basis to design affinity proteins with favorable properties. Beyond high affinity and specificity for their cognate target, they usually show high stability and high production yields in bacteria, yeast, or mammalian cells. In addition to these favorable properties, their ease of engineering makes them useful for many applications. Until the past few years, the generation of VHH involved the immunization of a Camelidae with the target antigen, followed by a phage display selection using phage libraries encoding the VHH repertoire of the animal blood sample. However, this approach is constrained by the accessibility to the animals, and the output relies on the animal’s immune system.
Recently, synthetic VHH libraries have been designed to avoid the use of animals. Here, we describe the construction of VHH combinatorial libraries and their use for the selection of binders by ribosome display, a fully in vitro selection technique.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hamers-Casterman C, Atarhouch T, Muyldermans S et al (1993) Naturally occurring antibodies devoid of light chains. Nature 363:446–448
de Marco A (2020) Recombinant expression of nanobodies and nanobody-derived immunoreagents. Protein Expr Purif 172:105645
Goldman ER, Liu JL, Zabetakis D, Anderson GP (2017) Enhancing stability of camelid and shark single domain antibodies: an overview. Front Immunol 8:865
Pia EAD, Martinez KL (2015) Single domain antibodies as a powerful tool for high quality surface plasmon resonance studies. PLoS One 10:e0124303
Huang C, Ren J, Ji F et al (2020) Nanobody-based high-performance immunosorbent for selective beta 2-microglobulin purification from blood. Acta Biomater 107:232–241
Verheesen P, ten Haaft MR, Lindner N et al (2003) Beneficial properties of single-domain antibody fragments for application in immunoaffinity purification and immuno-perfusion chromatography. Biochim Biophys Acta 1624:21–28
Rasmussen SGF, Choi H-J, Fung JJ et al (2011) Structure of a nanobody-stabilized active state of the β(2) adrenoceptor. Nature 469:175–180
Löw C, Yau YH, Pardon E et al (2013) Nanobody mediated crystallization of an archeal mechanosensitive channel. PLoS One 8:e77984
Yamagata M, Sanes JR (2018) Reporter–nanobody fusions (RANbodies) as versatile, small, sensitive immunohistochemical reagents. Proc Natl Acad Sci 115:2126–2131
Kijanka M, van Donselaar EG, Muller WH et al (2017) A novel immuno-gold labeling protocol for nanobody-based detection of HER2 in breast cancer cells using immuno-electron microscopy. J Struct Biol 199:1–11
Baral TN, Magez S, Stijlemans B et al (2006) Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor. Nat Med 12:580–584
Ackaert C, Smiejkowska N, Xavier C et al (2021) Immunogenicity risk profile of nanobodies. Front Immunol 12:632687
Bridoux J, Broos K, Lecocq Q et al (2020) Anti-human PD-L1 nanobody for immuno-PET imaging: validation of a conjugation strategy for clinical translation. Biomol Ther 10:E1388
Xavier C, Vaneycken I, D’huyvetter M et al (2013) Synthesis, preclinical validation, dosimetry, and toxicity of 68Ga-NOTA-anti-HER2 Nanobodies for iPET imaging of HER2 receptor expression in cancer. J Nucl Med 54:776–784
Chanier T, Chames P (2019) Nanobody engineering: toward next generation immunotherapies and immunoimaging of cancer. Antibodies (Basel) 8:13
Morrison C (2019) Nanobody approval gives domain antibodies a boost. Nat Rev Drug Discov 18:485–487
Pardon E, Laeremans T, Triest S et al (2014) A general protocol for the generation of Nanobodies for structural biology. Nat Protoc 9:674–693
Yan J, Li G, Hu Y et al (2014) Construction of a synthetic phage-displayed Nanobody library with CDR3 regions randomized by trinucleotide cassettes for diagnostic applications. J Transl Med 12:343
Yan J, Wang P, Zhu M et al (2015) Characterization and applications of Nanobodies against human procalcitonin selected from a novel naïve Nanobody phage display library. J Nanobiotechnol 13:33
Moutel S, Bery N, Bernard V et al (2016) NaLi-H1: a universal synthetic library of humanized nanobodies providing highly functional antibodies and intrabodies. eLife 5:e16228
McMahon C, Baier AS (2018) Yeast surface display platform for rapid discovery of conformationally selective nanobodies. Nat Struct Mol Biol 25:289–296
Zimmermann I, Egloff P, Hutter CAJ et al (2020) Generation of synthetic nanobodies against delicate proteins. Nat Protoc 15:1707–1741
Chen X, Gentili M, Hacohen N, Regev A (2021) A cell-free nanobody engineering platform rapidly generates SARS-CoV-2 neutralizing nanobodies. Nat Commun 12:5506
Mouratou B, Schaeffer F, Guilvout I et al (2007) Remodeling a DNA-binding protein as a specific in vivo inhibitor of bacterial secretin PulD. Proc Natl Acad Sci U S A 104:17983–17988
Kalichuk V, Renodon-Corniere A, Behar G et al (2018) A novel, smaller scaffold for Affitins: showcase with binders specific for EpCAM. Biotechnol Bioeng 115:10
Kalichuk V, Kambarev S, Behar G et al (2020) Affitins: ribosome display for selection of Aho7c-based affinity proteins. Methods Mol Biol 2070:19–41
Hanes J, Pluckthun A (1997) In vitro selection and evolution of functional proteins by using ribosome display. Proc Natl Acad Sci U S A 94:4937–4942
Amstutz P, Binz HK, Zahnd C, Pluckthun A (2006) Ribosome display: in vitro selection of protein-protein interactions. In: Celis J (ed) Cell biology – a laboratory handbook. Elsevier Academic Press, pp 497–509
Acknowledgments
The authors thank all previous members of the laboratory who helped to develop this protocol.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Guilbaud, A., Pecorari, F. (2023). Construction of Synthetic VHH Libraries in Ribosome Display Format. In: Zielonka, S., Krah, S. (eds) Genotype Phenotype Coupling. Methods in Molecular Biology, vol 2681. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-3279-6_2
Download citation
DOI: https://doi.org/10.1007/978-1-0716-3279-6_2
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-3278-9
Online ISBN: 978-1-0716-3279-6
eBook Packages: Springer Protocols